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Subcortical white matter in the adult human brain contains a population of interneurons that helps regulate
cerebral blood flow.We investigated the fate of these neurons following subcortical white matter demyelination.
Immunohistochemistry was used to examine neurons in normal-appearing subcortical white matter and seven
acute and 59 chronic demyelinated lesions in brains from nine patients with multiple sclerosis and four controls.
Seven acute and 44 of 59 chronic multiple sclerosis lesions had marked neuronal loss. Compared to surrounding
normal-appearing white matter, the remaining 15 chronic multiple sclerosis lesions contained a 72% increase in
mature interneuron density, increased synaptic densities and cells with phenotypic characteristics of immature
neurons. Lesion areas with increased neuron densities contained a morphologically distinct population of acti-
vated microglia. Subventricular zones contiguous with demyelinated lesions also contained an increase in cells
with phenotypes of neuronal precursors.These results support neurogenesis in a subpopulation of demyelinated
subcortical white matter lesions in multiple sclerosis brains.
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Introduction
In the past 15 years, there has been a paradigm shift in
research on multiple sclerosis. Although myelin and the
oligodendrocyte are the primary targets of inflammatory
demyelination, permanent disability in multiple sclerosis
patients is now attributed to the impact that this process
has on the viability of axons and neurons (Bjartmar et al.,
2003). Numerous studies have confirmed the extent of
axonal damage in white matter lesions (Ferguson et al., 1997;
Trapp et al., 1998), as well as the extent of grey matter
demyelination and injury to neurons (Brownell and Hughes,
1962; Kidd et al., 1999; Peterson et al., 2001). In addition,
there is extensive cognitive impairment in multiple sclerosis
patients (Rao et al., 1991; Beatty, 1993), which may also be
attributed to the effect of demyelination on neuronal
function. Therefore, the mechanisms of neuronal injury
and identification of potential targets for neuroprotection
have become important areas of research focus.
Study of neuronal injury in grey matter is difficult to
perform because of the high neuronal density in these areas.
An alternative location more conducive to analysis of neu-
rons is the subcortical white matter. Neurons in this region
are less dense than in grey matter, but display an extensive
network of dendrites and receive ultrastructurally confirmed
synaptic input (Kostovic and Rakic, 1980; Chun and Shatz,
1989; Okhotin and Kalinichenko, 2003). White matter
neurons regulate vascular tone (Okhotin and Kalinichenko,
2003) based upon their expression of the vasoconstrictors,
somatostatin (Kostovic et al., 1991) and neuropeptide Y
(NPY; Kuljis and Rakic, 1989; Delalle et al., 1997), and
neuronal nitric oxide synthase (nNOS), the enzyme that
synthesizes the vasodilator, nitric oxide (Okhotin and
Kalinichenko, 2003). Subcortical white matter neurons
are readily identifiable in species with large white matter
volume, such as primates and cats (Kostovic and Rakic, 1980;
Chun and Shatz, 1989; Okhotin and Kalinichenko, 2003).
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The present report investigates the fate of subcortical
white matter neurons in the lesions of multiple sclerosis. Our
studies document the destruction of neurons during inflam-
matory demyelination of subcortical white matter. While
many chronically demyelinated lesions also showed marked
neuronal loss, we identified 15 lesion areas that contain a
72% increase in the density of cells that express unambig-
uous neuronal markers and that receive ultrastructurally
confirmed synaptic input. These results support neurogenesis
in a subpopulation of demyelinated subcortical white matter
lesions in multiple sclerosis brains.
Materials and Methods
Tissue
The brains of nine patients with multiple sclerosis and four
individuals without neurological disease were obtained by a rapid
autopsy protocol. The procurement of these tissues was approved
by Cleveland Clinic Institutional Review Board. Tables 1 and 2 list
the characteristics of these patients who were followed up at the
Cleveland Clinic. The brains were sliced (1cm thick) and fixed in
4% paraformaldehyde. Sixty-six demyelinated regions were macro-
scopically identified, removed and cryoprotected as described
previously (Trapp et al., 1998; Chang et al., 2000). The lesions
examined were all located within cerebral subcortical white matter
without extension into grey matter. The demyelinated lesions were
characterized as active or chronic, based upon the distribution of
myelin proteins and staining for the major histocompatibility
complex (MHC) Class II molecules, as described previously (Bo
et al., 1994).
Immunohistochemical analyses
Tissue blocks were sectioned (30mm thick) on a sliding microtome,
microwaved in 10mM citric acid buffer (pH 6.0) for 5min,
incubated in 3% hydrogen peroxide and 1% Triton X-100 in
phosphate-buffered saline for 30min and immunostained by the
avidin–biotin complex procedure with diaminobenzidine (DAB),
as described previously (Trapp et al., 1998; Chang et al., 2000).
Sections used for double-labelling experiments were pretreated as
above and incubated with two primary antibodies for 3–5 days
followed by fluorescently conjugated and biotinylated secondary
antibodies (Jackson ImmunoResearch Laboratories, West Grove,
PA) for 1–2h.
Antibodies
Sections were immunostained with antibodies specific for the
following molecules: proteolipid protein (PLP, Agmed, Bedford,
MA), MHC Class II, leukocyte common antigen, synaptophysin (all
from Dako, Glostrup, Denkmark), PSA-NCAM (BD Pharmigen,
San Diego, CA), nNOS (monoclonal, BD Biosciences, San Jose,
CA), microtubule-associated protein 2 (MAP2), calretinin (both
from Sigma, St Louis, MO), NeuN, calbindin, Dlx2, nNOS
(polyclonal), NPY, somatostatin, GAD67, parvalbumin (all from
Chemicon, Temecula, CA), myelin basic protein (MBP, Sternberger
Monoclonals, Baltimore, MD), Hu clone 16A11 (abcam,
Cambridge, MA) and Iba1 (Ito et al., 1998, monoclonal antibody
produced by Trapp Laboratory).
Microscopy
Sections were examined with an Axiophot microscope (Carl
Zeiss, Thornwood, NY) equipped with a Magnafire digital camera
Table 1 Features of multiple sclerosis patients studied
ID no. Age (years)/
gender
Race PMI
(h)
Type of
multiple
sclerosis
Disease
duration
(years)
EDSS Lesion type and number
Active Chronic
decreased
neurons
Chronic
increased
neurons
1 53/M C 17 SPMS 15 9.5 2 0 0
24 6 / M C 3 S P M S 2 3 8 41 0 0
36 3 / F C 5 S P M S 98 10 0
47 7 / F C 5 S P M S 4 68 0 1 3 1
56 1 / F A 1 0 S P M S 3 59 . 5 0 1 7 1 3
6 52/M C 5 SPMS 25 7 .5 0 1 1
7 56/M C 3 SPMS 33 9.5 0 1 0
8 57/F C 6 PPMS 15 6.5 0 1 0
94 3 / M C 3 R R M S 1 6 0 1 0
Race: C=Caucasian; A=African-American; PMI=post mortem interval.Type of multiple sclerosis: SP=secondary progressive;
PP=primary progressive; RR=relapsing remitting.
Table 2 Features of control patients studied
Age (years)/
gender
Race PMI
(h)
Proximate cause of death
65/F A 7 Acute myocardial infarction
47/F A 15 Disseminated intravascular coagulation
52/F A 12 Polymicrobial sepsis
65/M C 11 Acute pericardial hemorrhage
Race: A=African-American; C=Caucasian; PMI=post mortem
interval.
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scope (Leica Microsystems, Exton, PA) (Trapp et al., 1998; Chang
et al., 2000). Confocal laser intensity was adjusted to eliminate
‘bleed-through’. The images presented are stacks of 12–30 optical
sections that were scanned synchronously and compiled using Scion
image (Scion, Frederick, MD). Contrast and colour balance of
digital images were processed using Photoshop 7.0 (Adobe systems,
San Jose, CA).
Definition and quantification of neurons
For brightfield immunohistochemistry, only MAP2-positive cells
with unambiguous neuronal morphology were counted as neurons.
MAP2 is particularly suited to this analysis, because there is nor-
mally a low density of reactivity in the white matter. Other neuronal
markers, such as Class III beta-tubulin (Tuj1) and neurofilament
protein, show abundant immunoreactivity in axons of the white
matter, making it impossible to recognize the small population of
neuronal cell bodies in this region. MAP2-positive neurons had
large cell bodies (typically 20mm) and one or more dendrites
(typically 50mm or longer).
Brightfield preparations of single-labelled sections were used for
quantification of immunohistochemistry. Neuronal numbers were
quantified within the demyelinated area as well as in surrounding
normal-appearing white matter present in the same section but
positioned closer to the cortex (Fig. 4C). Comparison of lesion with
non-lesion area of the same sections controlled for any possible
regional variation in subcortical white matter neuronal density.
Since neuronal densities are always greater closer to the cortex
(Akbarian et al., 1996) (Fig. 4B and C), this analysis also permitted
the most stringent test of differences between lesion and non-lesion
areas. NeuN-positive and MAP2-positive neurons were counted in
lesion and control areas measuring 1mm
2. For large lesions, the
region of highest neuronal density was counted. NeuN-positive cells
were also quantified in subventricular zones (SVZs) contiguous
with demyelinated subcortical white matter and compared to
densities in SVZ contiguous with myelinated white matter present
in the same section (Fig. 5A). Such areas were present adjacent to 22
of the 59 lesions examined. Cell numbers were expressed as cells per
millimeter length of SVZ. SVZ cell number was also counted in a
total of three regions from two control brains. Differences were
compared using the Student’s t-test. =0.05.
Electron microscopic immunohistochemistry
Sections (30mm thick) from lesions of multiple sclerosis contain-
ing increased neuronal densities were immunostained with
synaptophysin antibodies and DAB as a substrate for detection of
specific staining. Areas containing punctate synaptophysin staining
were placed in 2.5% glutaraldehyde and 4% paraformaldehyde for
48h, osmicated and embedded in Epon by standard procedures.
Blocks were sectioned on a Leica ultramicrotome, placed on grids
and examined in a Phillips H-100 electron microscope.
Results
Subcortical white matter neurons
Subcortical white matter neurons were identified with
antibodies to MAP2, a cytoskeletal protein enriched in
dendrites and somas of mature neurons. The morphology
and distribution of white matter neurons in multiple
sclerosis normal-appearing white matter are identical to
controls. Morphologically, these MAP2-positive neurons
have fusiform cell bodies and one to three primary dendrites
with additional arborizations that are oriented parallel to
myelinated axons (Fig. 1A and B). Subcortical white matter
neurons express markers of cortical interneurons such as
calretinin (Fig. 1C) and calbindin (Fig. 4H), but do not
express glutamic acid decarboxylase or parvalbulmin
(Supplementary Fig. 1) (DeFelipe, 1997; Okhotin and
Kalinichenko, 2003). White matter neurons also express a
variety of vasoactive molecules, which supports their
involvement in the regulation of vascular tone (Okhotin
and Kalinichenko, 2003). Specifically, subsets of white matter
neurons express nNOS, the enzyme that synthesizes the
vasodilatory molecule nitric oxide (Fig. 1D), as well as the
vasoconstrictors, NPY (Fig. 1E) and somatostatin (Fig. 1F).
Inflammatory demyelination destroys white
matter neurons
Seven areas of acute demyelination in subcortical white
matter were identified by the absence of the myelin proteins
(Fig. 2A) and abundant MHC Class II-positive cells within
the demyelinated area (Fig. 2B). The MHC Class II-positive
cells were round, lipid-filled phagocytic macrophages,
indicative of recent demyelination (Fig. 2C, Supplementary
Fig. 2). When sections from these acute lesions were stained
for MAP2 and NeuN, neurons were rarely detected. When
present, most had fragmented MAP2-positive dendrites and
shrunken perikarya (Fig. 2D). While we cannot exclude the
possibility that some neurons within white matter lesions
might survive, these observations indicate that most, if not
all, white matter neurons are destroyed during inflammatory
demyelination of subcortical white matter.
Fifty-nine chronic lesions of multiple sclerosis were iden-
tified by a lack of myelin protein staining (Fig. 2E) and
paucity of MHC Class II-positive round, phagocytic macro-
phages (Fig. 2F). When these chronic lesions were examined
for neurons, 44 of the 59 had markedly reduced neurons
(Fig. 2G) and dystrophic changes in residual ones (Fig. 2H).
In addition, MAP2-positive dendrites that should have
extended into the lesions stopped at the borders (Fig. 2G).
These data provide additional support for the concept that
most, if not all, subcortical white matter neurons are
destroyed during inflammatory demyelination in multiple
sclerosis brains.
Chronic lesions with increased neuronal
densities
Fifteen of the 59 chronic lesions of multiple sclerosis studied
contained areas with increased density of MAP2-positive
neurons relative to adjacent non-lesion areas (Fig. 3A–C).
These lesions were present in three of the nine multiple
sclerosis brains examined. MAP2-positive neurons had a
mature appearance, but dendrites of these cells were not
2368 Brain (2008),131, 2366^2375 A.Chang et al.always oriented parallel to axons as in normal-appearing
subcortical white matter (cf. Fig. 3D and E). Lesions with
increased neuronal density also had increased density of
MHC Class II-positive cells (Fig. 3B). These cells had
relatively large cell bodies, prominent, stout processes
(Fig. 3F and G), and did not contain myelin degradation
products. Their morphology was distinct from the MHC
Class II-positive microglia with small cell bodies and short
thin processes in chronic lesions with decreased neurons
(Fig. 3H), and from the phagocytic macrophages present in
active lesions (Fig. 2C).
By double-label immunofluorescence and confocal micro-
scopy, MAP2-positive white matter neurons were also NeuN-
positive. Compared to normal-appearing white matter,
lesions with increased neuronal densities contained an
additional population of cells that were NeuN-positive and
MAP2-negative (Fig. 4A, arrowheads). All NeuN-positive
cells were also positive for Hu (Supplementary Fig. 3).
Expression of NeuN and Hu begins in post-mitotic imma-
ture neurons (Pincus et al., 1998; Sarnat et al., 1998).
Therefore, the NeuN-positive/MAP2-negative cells most
likely represent a population of immature cells, which are
Fig. 1 Morphology and immunophenotype of white matter neurons.MAP2-positive neurons in subcortical white matter have fusiform cell
bodies and one to three primary dendrites with additional arborizations that are oriented parallel to myelinated axons (A and B). Images
are from multiple sclerosis normal-appearing white matter; neuronal morphology and distribution are identical to controls.White matter
neurons also express other neuronal markers, such as calretinin, a marker of interneurons (C,r e d ) ,n N O S( D, red) and vasoactive mole-
cules, NPY (E, red) and somatostatin (F, green).White matter neurons also express the neuronal nuclear antigen, NeuN (F, red).Green
immunostain in C^E is MAP2. (C^E) Multiple sclerosis normal-appearing white matter. (F) Multiple sclerosis lesion (with increased
neurons). Scale bars: (A and B)5 0mm; (C^F)2 0mm.
Neurogenesis in multiple sclerosis lesions Brain (2008),131, 2366^2375 2369Fig. 2 Inflammatory demyelination is associated with decreased numbers of white matter neurons. Acute (A^D)a n dc h r o n i c( E^H)
lesions are characterized using immunohistochemistry for PLP (A and E) and MHC Class II (B,C and F). Normal myelin protein stain is
characterized by diffuse intense immunoreactivity as shown in the lower portion of panels A and E. Normal MHC Class II immunoreac-
tivity is shown in lower portion of panel F. An active lesion of multiple sclerosis characterized by loss of myelin (A
), myelin debris within
the demyelinated area and an even distribution of MHC Class II-positive macrophages throughout the lesion (B and C). All active lesions
had decreased neurons. Residual MAP2-positive neurons had shrunken perikarya (D, arrow) and fragmented dendrites (D,a r r o w h e a d s ) .
A chronic lesion shows loss of myelin (E
) and increased MHC Class II-positive cells at the lesion border (F).White matter neurons are
greatly reduced in most chronic multiple sclerosis lesions (G, MAP2). nNOS-positive neurons with shrunken perikarya (H)e x t e n d
processes to blood vessels (H
). Scale bars: (A, B, E^G)2 0 0mm; (C, D and H)2 0mm.
Fig. 3 A subset of chronic multiple sclerosis lesions shows an increased density of white matter neurons.The area of demyelination is
demonstrated by lack of PLP immunostaining (A). Leukocyte common antigen immunostaining demonstrates the lesion border as well as
increased staining within the lesion (B). Increased neuronal density is demonstrated by MAP2 staining (C). Neurons in non-lesion white
matter extendlongprocesses thatrun along axons (D, MAP2). Neurons that are increased in white matter lesions extend shorter dendrites
(E, MAP2).Double-label immunofluorescence and confocal microscopy show that MAP2 immunoreactivity is not present in microglial cells
indicating that the increased MAP2 immunoreactivity in these lesions is not due to phagocytosis by microglia (F, MAP2, green, microglial
marker, Iba1, red). Microglial cell morphology predicts whether lesions will contain increased neurons. In multiple sclerosis lesions contain-
ing increased neurons, microglia are abundant and have large cell bodies and multiple thick processes (F,I b a 1 ,r e d ,G, MHC Class II). In
lesions where neurons are absent, microglia density is low, and these cells extend few thin processes (H, MHC Class II). Scale bars: (A^C)
200mm; (D and E)1 0 0mm; (F^H)2 0mm.
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tiated into neurons that polarize their processes into mature
dendrites and axons. The 15 lesions with increased neurons
were immunostained with antibodies to MAP2 and NeuN,
and their density compared to normal-appearing white
matter located closer to the cerebral cortex (Fig. 4B and C).
The density of MAP2-positive neurons in lesions was
increased by 72% and NeuN-positive cell density was
increased by 130% (P50.0001, Fig. 4D). These data support
an increase in both mature NeuN-positive/MAP2-positive
neurons and immature NeuN-positive/MAP2-negative neu-
rons in a subset of chronic lesions in multiple sclerosis brains.
Since neurons in subcortical white matter receive synaptic
input (Kostovic and Rakic, 1980), we investigated whether
demyelinated regions with increased neuronal densities also
contained increased synapses by double-labelling sections
with antibodies specific for MAP2 and synaptophysin,
a protein enriched in synaptic vesicles (Fig. 4E and F).
MAP2-positive neuronal perikarya and dendrites in normal-
appearing white matter were closely apposed by putative
synaptic boutons as identified by punctate synaptophysin
staining (Fig. 4F). Compared to normal-appearing white
matter, lesions with increased neuronal density contained a
dramatic increase in punctate synaptophysin staining appos-
ing both neuronal perikarya and dendrites (Fig. 4E). To
validate synaptic innervation of these neurons at the ultra-
structural level, 30mm thick sections were immunostained
with synaptophysin antibodies using DAB as a chromogen,
embedded in Epon, and sectioned for electron microscopic
examination. Ultrastructural preservation was adequate for
localization of DAB signal in thin sections. The punctate
staining identified at the light microscopic level was confined
to small, round to oval, membrane-bound structures con-
taining vesicles and met ultrastructural criteria for synaptic
Fig. 4 Evidence for neurogenesis in multiple sclerosis lesions.Confocal image of a section double-labelled for MAP2 (A,g r e e n )a n dN e u N
(A,r e d ) .A l lM A P 2 - p o s i t i v ec e l l sa r eN e u N - p o s i t i v e( A, arrows), but some NeuN-positive cells are MAP2-negative (A,a r r o w h e a d s ) .
Schematic diagrams illustrate the normal distribution of white matter neurons (B) and the appearance of multiple sclerosis lesions with
increased neurons (lower circle in C). In 15 of 59 lesions, MAP2-positive cell density is increased 72% (D) compared to locations closer to
the cortex (upper circle in C). NeuN-positive cell density is increased130% when compared to normal white matter (D). Synaptophysin-
positive (red) puncta closely appose MAP2-labelled (green) neuronal soma and dendrites in a multiple sclerosis lesion (E) and in control
white matter (F). Neurons in the lesions radiate highly branched dendrites and receive an increased density of synaptophysin-positive
puncta compared with control neurons. Electron microscopy of synaptophysin-stained multiple sclerosis lesion with increased neuronal
density (G) demonstrates that synaptophysin immunoreactivity is present in membrane-bound structures apposed to neurons consistent
with presynaptic endings (dark staining on right, N=neuronal nucleus). Neurons in multiple sclerosis lesions also express proteins specific
for interneurons including calbindin (H, green), somatostatin (H,r e d )a n dn N O S( I, red, MAP2, green). Scale bars: (A, E, F,H and I)
20mm; (G) 250nm. Error bars: SEM.
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axodendritic and axosomatic synapses typical of interneu-
ronal innervation. No axospinous or asymmetric synapses
were seen. This provides unambiguous ultrastructural
evidence that the increased cells recognized by MAP2 and
NeuN staining are neurons. In addition to MAP2 and NeuN,
the neurons within these lesions showed functional differ-
entiation as demonstrated by expression of calbindin,
somatostatin and nNOS (Fig. 4H and I).
The subventricular zone as a source of cells
c o m m i t t e dt on e u r o g e n e s i s
To investigate whether the SVZ is a possible source of neu-
rons in multiple sclerosis brains, we compared the number of
NeuN-positive cells in SVZs that border demyelinated regions
and normal-appearing white matter in 22 sections (Fig. 5A).
To control for possible differences based upon brain location,
the non-lesion data were obtained from the same section as
the lesion data. In SVZs that border normal-appearing
white matter, an average of two NeuN-positive cells was
detected per millimeter length of SVZ (Fig. 5B), and 1.3
cells/mm were detected in SVZ from normal control subjects
(data not shown). In contrast, there was a 3.5-fold increase
(P50.001) in NeuN-positive cells per millimeter of SVZs
that bordered demyelinated white matter (Fig. 5C and D).
The NeuN-positive cells were Hu-positive (Supplementary
Fig. 3). Some were PSA-NCAM-positive and extended a few
processes from small round cell bodies (Fig. 5E). Since pro-
genitor cells committed to interneuron production express
the transcription factor Dlx2 (Flames and Marin, 2005),
we double-labelled sections with NeuN and Dlx2. Most
NeuN-positive cells in the SVZ expressed Dlx2 (Fig. 5F).
Collectively, these data support the SVZ as one source of new
neurons in multiple sclerosis brains.
Discussion
This report establishes that subcortical white matter inter-
neurons are destroyed during the inflammatory demyelina-
tion that occurs in the brains of individuals with multiple
sclerosis. In response to this neuronal loss, some chronically
demyelinated brain regions contained neurons at densities
that, on average, exceeded those in normal-appearing white
matter by 72%. These neurons express immunophenotypic
markers of fully differentiated interneurons, have the shape
of mature neurons and receive ultrastructurally confirmed
synapses. Demyelinated brain regions with increased neuro-
nal densities also contain a morphologically distinct popula-
tion of activated microglial cells and a significant increase in
cells with characteristics of immature neurons that may
originate, in part, from adjacent SVZs. These findings sup-
port the possibility that white matter interneurons can be
replaced following their destruction.
All acute lesions and 44 of 59 chronic lesions analysed in
the present study had marked neuronal loss and dystrophic
changes in residual neurons. This susceptibility of white
matter neurons to inflammatory demyelinating environ-
ments has not been recognized previously. It cannot be
mediated by loss of myelin sheaths because interneurons are
not myelinated. As proposed for axonal transection in acute
white matter lesions (Trapp et al., 1998), it is likely that white
Fig. 5 Immature neurons are increased in the SVZ bordering multiple sclerosis lesions. NeuN-positive cells were quantified in the SVZ
bordering periventricular white matter lesions (A, red box) and adjacent non-lesion areas (A, blue box). NeuN-positive cells are rare in
the non-lesion SVZ (B, arrows) but frequent in the adjacent lesion SVZ (C, arrows).There is a 3.5-fold increase of NeuN-positive cell
density in the SVZ of the lesions compared to the non-lesion area (D). Some NeuN-positive cells (E, NovaRed, F,r e d )i nt h eS V Zb o r -
dering a periventricular white matter lesion have PSA-NCAM-positive processes (E, brown cytoplasmic staining, DAB, arrows) and
Dlx2-positive nuclei (F, green, NeuN, red). Scale bars: (A)2m m ;( B and C)2 0 0mm; (E and F)2 0mm. Error bars: SEM.
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linating environment. Indeed, the inflammatory microenvir-
onment contains a variety of substances that could
potentially injure neurons, including proteolytic enzymes,
cytokines, oxidative products and free radicals produced by
activated immune and glial cells (Thery et al., 1991; Chao
et al., 1992; Giulian et al., 1993; Moore and Thanos, 1996;
Cardona et al., 2006). In addition, demyelination of the
cerebral cortex occurs without significant influx of hema-
togenous leukocytes and frank destruction of neurons
(Peterson et al., 2001). It is therefore possible that mech-
anisms that prevent influx of hematogenous leukocytes
during grey matter demyelination evolved as a means to
protect neurons from destruction.
An important question regarding these studies is the
mechanism by which the increased neuronal densities occur.
It is possible that an increase in white matter neurons could
occur if cortical blocks were oriented tangentially and then
sectioned into or close to cortical layers of adjacent sulci.
Since we carefully orient our tissue blocks and maintain grey
matter–white matter orientations through serial sections, we
are confident that increased neuronal densities occur in
demyelinated subcortical white matter. Chronic white matter
lesions often have extensive cell loss. In gross brain slices,
there is often parenchymal collapse such that the thickness of
tissue within a lesion is reduced relative to the adjacent non-
lesion tissue. It is possible that atrophy could increase the
density of neurons that may have survived acute demyelina-
tion. However, there was no consistent difference in gross
atrophy between the chronic lesions with and without
increased neuronal densities. Therefore, parenchymal atro-
phy and/or survival of pre-existing neurons cannot account
for the observation of increased neurons in a subset of
chronic lesions.
We also considered whether the increased neuronal
density arises from migration of mature neurons into the
lesion. There is no precedence for migration of mature
neurons in the adult CNS. Nevertheless, recent data has
documented the translocation of synaptically connected
interneurons in the early postnatal rat dentate gyrus
(Morozov et al., 2006). We do not favour this hypothesis
for our data in the mature human nervous system for two
reasons. First, if mature neurons were migrating from
another location, it would also be expected that a decrease
in neuronal density would occur outside of the lesion, which
does not appear to be the case. Second, because of the low
density of white matter neurons in adult control brain, a
migration model would require neurons to translocate
distances that are much greater than that observed in the
post-natal rat dentate gyrus. Furthermore, the extensive
dendritic branches of white matter neurons present a major
obstacle to migration.
We favour the interpretation that increased neuronal
densities arise from neurogenesis. Our studies demonstrate
an increase in the absolute number of cells with unambig-
uous neuronal phenotype based upon morphology, antigen
expression and ultrastructural evidence of synaptic connec-
tions. These phenotypes are similar to the interneurons
normally found in subcortical white matter and support
functional replacement of previously destroyed neurons.
These results fulfill several criteria proposed to support
identification of new neurons (Rakic, 2002a, b). Additional
criteria for neurogenesis include evidence for recent neuronal
cell proliferation (Rakic, 2002a, b). BrdU incorporation was
used to provide evidence of hippocampal neurogenesis in
post-mortem brains of patients who had received BrdU as
part of a cancer research protocol (Eriksson et al., 1998). We
have no knowledge that multiple sclerosis patients have
received BrdU premortem, and the possibility of performing
such studies on a prospective basis is unlikely for ethical
reasons. The proliferation marker, PCNA, was used to
support neurogenesis in post-mortem human Huntington
disease brains (Curtis et al., 2003). We have been unable to
reliably localize proliferation antigens, such as PCNA or Ki-
67 in cells expressing phenotypic markers of immature
neurons. Multiple sclerosis patients die 20–40 years after the
clinical onset of the disease, and the inflammatory demye-
lination to which white matter neurons are susceptible
predominates during the early stages. Newly generated
neurons may have exited the cell cycle and migrated to
their destination decades prior to the patient’s death; so, it
would not be surprising that proliferation antigens are no
longer detectable.
What are the possible sources for new neurons in chronic
multiple sclerosis lesions? It is possible that the MAP2-
positive neurons differentiated from immature cells normally
present in adult white matter. One candidate cell expresses
the chondroitin sulfate proteoglycan, NG2, and platelet-
derived growth factor receptor alpha (Chang et al., 2000;
Nunes et al., 2003). While characterized as a glial progenitor
cell (for review, see Nishiyama, 2007) that can be present in
chronic multiple sclerosis lesions (Chang et al., 2000), these
cells also have the ability to produce interneurons during
rodent brain development (Aguirre et al., 2004; Dayer et al.,
2005), and when isolated from adult human brain (Nunes
et al., 2003). Another source is the SVZ. The SVZ is the
source of all progenitor cells during brain development, and
the adult mammalian brain contains multipotent progenitor/
stem cells that can proliferate in vivo and produce neurons,
astrocytes and oligodendrocytes in vitro (Pincus et al., 1998;
Johansson et al., 1999; Kukekov et al., 1999; Roy et al., 2000;
Alvarez-Buylla and Garcia-Verdugo, 2002; Sanai et al., 2004).
In the SVZ adjacent to demyelinated lesions, the density of
NeuN-positive cells was increased, and these cells express
PSA-NCAM and Dlx2, markers expressed by committed
neuronal progenitor cells (Flames and Marin, 2005; Bonfanti,
2006). These observations are consistent with reports that
brain injury or destruction can induce progenitor cell
proliferation in the SVZ of rodents and primates (Calza
et al., 1998; Nait-Oumesmar et al., 1999; Jin et al., 2001;
Arvidsson et al., 2002; Nakatomi et al., 2002; Parent et al.,
2002a, b; Tonchev et al., 2003, 2005; Tattersfield et al., 2004).
Neurogenesis in multiple sclerosis lesions Brain (2008),131, 2366^2375 2373The present study also suggests that demyelinated white
matter produces signals that either prevent or enhance the
ability of neurons to repopulate lesions. We observed an
association between an abundant and morphologically
distinct population of activated microglia and regions of
multiple sclerosis lesions with increased neuronal densities.
Whether this association is a cause or consequence of
increased neurons is unknown; however, a recent report
suggests that activated microglia can promote neurogenesis
from neural stem cells in vitro (Walton et al., 2006). This
raises the possibility that activated microglia provide a
positive signal for neuronal differentiation and/or survival.
In summary, we have presented data that support neuro-
genesis in the lesions of multiple sclerosis. We recognize
that we cannot eliminate the possibility that neurons with
extensive dendritic processes migrated over substantial dis-
tances to the lesion area. If this is the case, we argue that such
a phenomenon is unprecedented in the adult mammalian
brain and is of bigger impact to the neuroscience field than
our preferred interpretation of neurogenesis.
Supplementary material
Supplementary material is available at Brain online.
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